Biogen: Competing With Eli Lilly's Kisunla, Safety Gives Market Edge
Source: SeekingAlpha
2025-12-30 08:57:41 ET
Since my October article , Biogen Inc. ( BIIB ) stock has risen 18.4%, outperforming the S&P 500 [2.9% return] ( SPY ), as well as two "bellwethers" for the biotech investors, the iShares Biotechnology ETF [14%] ( IBB ) and VanEck Biotech ETF [10.1%] ( BBH )....
Read the full article on Seeking Alpha
For further details see:
Biogen: Competing With Eli Lilly's Kisunla, Safety Gives Market Edge
iShares Biotechnology ETF
NASDAQ: IBB
IBB Trading
-0.92% G/L:
$165.11 Last:
850,028 Volume:
$167.72 Open:
